Drugs / Bio-C Temp
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT07101029 | Aug 2025 → Jul 2026 overdue | acute apical periodontitis | Cairo University | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT07423663 | Sep 2024 → Mar 2026 overdue | periapical periodontitis | Suez Canal University | Active not recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07396688 | Sep 2025 → Feb 2026 | — | Ankara University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bio-C Temp | “Bioceramic intracanal medicament (Bio-C Temp®, Angelus):
A bioceramic-based intracanal medicament used between treatment sessions.” NCT07396688 ↗2“Patients receiving Calcium silicate based (Bio-C Temp) intracanal medication” NCT07423663 ↗ |
| Modality | Other / unclassified | “A bioceramic-based intracanal medicament used between treatment sessions.” NCT07396688 ↗ |
| Route | Other | “placed in the root canal system during the interappointment period of multi-visit endodontic retreatment.” NCT07396688 ↗ |